Bill targets aggressive online sales
This article was originally published in The Rose Sheet
The use of "negative-option" schemes would be regulated under legislation introduced May 19 by Sen. Jay Rockefeller, D-W.Va. Negative-option strategies, in which marketers lure consumers with "free trial" offers and then charge their credit cards, are often used by online vendors of weight-loss "supplements" and have attracted Federal Trade Commission attention. S. 13386, the "Restore Online Shoppers' Confidence Act," would also prohibit marketers from using misleading post-transaction ads and from transferring consumer billing information to third-party sellers. The legislation follows a November 2009 report on aggressive sales tactics and awaits action by the Senate Commerce, Science and Transportation Committee
You may also be interested in...
Formycon’s CEO has offered the latest indication that the coronavirus outbreak could provide a tailwind for biosimilars, as the firm gave an update on its biosimilars pipeline – including ranibizumab, ustekinumab, aflibercept and an undisclosed molecule, as well as other unrevealed projects – and how it has been affected by the pandemic.
With the formal, virtual kick-off meeting set for 23 July, US FDA and sponsors are looking at a transformed landscape as they discuss what the next five years of user fees will look like.
Keeping Track: Approvals For Phexxi, Kynombi; New Claims For Lynparza, Alunbrig, Tecentriq; Intercept May Miss NASH User Fee Date
The latest drug development news and highlights from the Pink Sheet US FDA Performance Tracker.